- Home
- GNTA vs PLSM Comparison
GNTA vs PLSM Comparison
Compare GNTA & PLSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNTA | PLSM |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | Italy | Israel |
| Employees | 13 | 63 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 23.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GNTA | PLSM |
|---|---|---|
| Price | $0.72 | $3.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 38.1K | 1.9K |
| Earning Date | 03-24-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.59 | $3.00 |
| 52 Week High | $10.00 | $6.85 |
Technical Indicators
Market Signals| Indicator | GNTA | PLSM |
|---|---|---|
| Relative Strength Index (RSI) | 49.00 | 41.46 |
| Support Level | $0.71 | $3.00 |
| Resistance Level | $0.75 | $3.93 |
| Average True Range (ATR) | 0.06 | 0.15 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 65.56 | 7.84 |
Price Performance
Historical ComparisonAbout GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About PLSM Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.